Grayscale Decentraland Trust (MANA) is a US-based company operating in industry. The company is headquartered in Stamford, Connecticut. The company went IPO on 2022-05-13. Grayscale Decentraland Trust (MANA) (the Trust) is an investment vehicle that enables investors to gain exposure to the token underlying the Decentraland platform in the form of a security. The Trust holds MANA and, from time to time on a periodic basis, issues Creation Baskets in exchange for deposits of MANA. As a passive investment vehicle, the Trust’s investment objective is for the value of the Shares (based on MANA per Share) to reflect the value of the MANA held by the Trust, determined by reference to the Reference Rate Price, less the Trust’s expenses and other liabilities. While an investment in the Shares is not a direct investment in MANA, the Shares are designed to provide investors with a cost-effective and convenient way to gain investment exposure to MANA. The activities of it are limited to issuing Baskets in exchange for MANA transferred to the Trust as consideration in connection with the creations and others. Its sponsor is Grayscale Investments Sponsors, LLC.
Grayscale Decentraland Trust (MANA)의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Pacira Biosciences Inc 주요 수익원은 Non-opioid Pain Management and Regenerative Health Solutions이며, 최신 수익 발표에서 수익은 674,978,000입니다. 지역별로는 United States, European Union, United Kingdom and Canada이 Pacira Biosciences Inc의 주요 시장이며, 수익은 674,978,000입니다.
Grayscale Decentraland Trust (MANA)은 수익성이 있나요?
예, 최신 재무제표에 따르면 Pacira Biosciences Inc의 순이익은 $7입니다.
Grayscale Decentraland Trust (MANA)에 부채가 있나요?
예, Pacira Biosciences Inc의 부채는 571입니다.
Grayscale Decentraland Trust (MANA)의 발행 주식은 몇 주인가요?